Scinai Immunotherapeutics Stock Quote SCNI - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.14

Bid

4.12

Ask

4.30

Volume

110,535

4.10 Day's Range 4.73

0.00 52 Week Range 0.00

Market Cap

2.038M

Previous Close

4.39

Open

4.13

Last Trade

4.12

Last Trade Time

Financial Volume

$ 485,052

VWAP

4.3882

Average Volume (3m)

Shares Outstanding

464,293

Dividend Yield

PE Ratio

Earnings Per Share (EPS)

Revenue

Net Profit

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic ... BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Coml Physical, Biologcl Resh

Website

www.biondvax.com

Headquarters

Jerusalem, Jerusalem, Isr

Founded

2012

Scinai Immunotherapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SCNI. The last closing price for Scinai Immunotherapeutics was $4.39. Over the last year, Scinai Immunotherapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Scinai Immunotherapeutics currently has 464,293 shares outstanding. The market capitalization of Scinai Immunotherapeutics is $2.04 million.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Scinai Immunotherapeutics Announces promising results in an in-vivo proof-of-concept psoriatic human skin model

Scinai Immunotherapeutics Announces promising results in an in-vivo proof-of-concept psoriatic human skin model PR Newswire JERUSALEM, July 15, 2024 JERUSALEM, July 15, 2024 /PRNewswire/...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity

Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity PR Newswire JERUSALEM...

Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements PR Newswire JERUSALEM, July 3, 2024 JERUSALEM, July 3, 2024...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	158.15M
CMAXCareMax Inc	$ 5.19 (228.48%)	102.64M
NUKKNukkleus Inc	$ 0.499 (55.94%)	26.2M
SNOASonoma Pharmaceuticals Inc	$ 0.423 (37.34%)	4.88M
ONDSOndas Holdings Inc	$ 1.1297 (34.06%)	2.19M
CGBSCrown LNG Holdings Ltd	$ 0.9902 (-29.77%)	3.29M
LGCBLinkage Global Inc	$ 3.7833 (-27.45%)	166.7k
SPECSpectaire Holdings Inc	$ 0.395 (-24.76%)	1.78M
GSUNGolden Sun Health Technology Group Ltd	$ 5.07 (-24.55%)	155.37k
SLNASelina Hospitality PLC	$ 0.0364 (-23.04%)	75.77M
NVDANVIDIA Corporation	$ 123.54 (4.76%)	239M
SQQQProShares UltraPro Short QQQ	$ 8.09 (-4.37%)	183.65M
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	158.15M
SERVServe Robotics Inc	$ 8.73 (15.63%)	151.56M
NCPLNetcapital Inc	$ 0.1118 (7.50%)	124.37M